These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10861026)

  • 21. Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.
    Graca L; Daley S; Fairchild PJ; Cobbold SP; Waldmann H
    BMC Immunol; 2006 Apr; 7():9. PubMed ID: 16638128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
    Xu H; Zhu Z; Huang Y; Bozulic LD; Hussain LR; Yan J; Ildstad ST
    Transplantation; 2012 Mar; 93(5):469-76. PubMed ID: 22228418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The abrogation of allosensitization following the induction of mixed allogeneic chimerism.
    Colson YL; Schuchert MJ; Ildstad ST
    J Immunol; 2000 Jul; 165(2):637-44. PubMed ID: 10878335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.
    Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP
    J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
    Anam K; Amare MF; Zins SR; Davis TA
    Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.
    Forman D; Welsh RM; Markees TG; Woda BA; Mordes JP; Rossini AA; Greiner DL
    J Immunol; 2002 Jun; 168(12):6047-56. PubMed ID: 12055213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation.
    Umemura A; Morita H; Li XC; Tahan S; Monaco AP; Maki T
    J Immunol; 2001 Sep; 167(6):3043-8. PubMed ID: 11544287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.
    Prigozhina TB; Gurevitch O; Elkin G; Morecki S; Yakovlev E; Slavin S
    Exp Hematol; 2003 Jan; 31(1):81-8. PubMed ID: 12543110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed chimerism to induce tolerance for solid organ transplantation.
    Wren SM; Nalesnik M; Hronakes ML; Oh E; Ildstad ST
    J Pediatr Surg; 1991 Apr; 26(4):439-43. PubMed ID: 2056405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion.
    Higuchi M; Zeng D; Shizuru J; Gworek J; Dejbakhsh-Jones S; Taniguchi M; Strober S
    J Immunol; 2002 Nov; 169(10):5564-70. PubMed ID: 12421933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.
    Seung E; Iwakoshi N; Woda BA; Markees TG; Mordes JP; Rossini AA; Greiner DL
    Blood; 2000 Mar; 95(6):2175-82. PubMed ID: 10706892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.